April Japanese price cut a mixed bag of give and take
This article was originally published in Scrip
Executive Summary
The official release of Japan's new reimbursement tariff showing the revised prices for individual drugs that will come into effect on 1 April reveals a complex mixture of relative impact for products and companies, although as usual the figures are overwhelmingly negative.